Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » Patient Stories » Tayla Barreau, SA

Tayla Barreau, SA

Tayla Barreau

On Monday the 19th March (my husband David’s birthday) we were in transit to the Women’s and Children’s Hospital in Adelaide, after receiving a referral from our local GP. Our eldest daughter Tayla had an ultrasound, MRI and CAT scan just days before, all which detected a mass in her abdomen, this warranted further investigation by the hospital. Even more bizarre was the fact that she had found this lump herself.

Her symptoms were at times vague; feeling dizzy, heart palpitations, night sweats, and frequent urination…not something you could put your finger on. She still carried on as normal went to school and played sport as these symptoms didn’t seem to hinder her in any way. That trip to the hospital was one of worry, concern and anxiety. We had already spent almost 12 months there with our first son Luke who had cancer.

A biopsy was carried out the next day, and it wasn’t long before the surgeon was speaking to us, and from the pathology it appeared to be a ‘Paraganglioma’ a tumour located in her abdomen. Most of these are benign 97% but 3% can be cancerous. We would await the final results which would take a few days.

On the day of my birthday March 22nd the initial diagnosis was confirmed. An operation was carried out in April and a 5cm tumour was removed. Tayla recovered well and life went back to normal. During her stay in hospital we were referred onto the Familial Cancer Unit at the WCH for genetic testing. As these tumours are extremely rare in children, it was possible it was hereditary. It took over four months but eventually we were told that Tayla had a genetic mutation, called SDHB.

At this point my husband and I were tested and he tested positive for the gene. Our youngest daughter Mia, also has the mutation. So what does this all mean, well the girls now have a 50% chance of passing it onto their offspring and they all will need lifetime surveillance and blood/urine tests and annual scans, to monitor this.
Tayla is now more likely to develop other tumours, as a result of this gene. Her risk of developing other types of cancer also significantly higher.

Since her initial diagnosis she again was admitted for another operation in January of 2013, where two more tumours were removed from her abdomen. She now has PET scans as well to detect any tumours.

*A Paraganglioma is a type of neuroendocrine tumour, and are rare in children. Our first son Luke (12 months) was diagnosed with neuroblastoma (also a type of neuroendocrine tumour) in 1997, but lost his battle just over twelve months later. His DNA showed no evidence of this genetic mutation, just really rotten luck.

Jackie Barreau (mother)

Patient Stories

Cassie, QLD

I’m a 36-year-old mum of three little humans – things like this just doesn’t happen to people like me. Until all of a sudden it does, and everything changes

Lana, NSW

Blurry vision had led to a diagnosis of Von Hippel-Lindau (VHL) disease – a condition where multiple tumours grow in various parts of the body, including the brain, spinal cord, abdominal organs, and eyes.

Simon, VIC

We need greater awareness of VHL, better education for healthcare professionals, and up-to-date resources to guide patients through diagnosis and care.

Vanessa, ACT

I was in my late twenties when I first realised something wasn’t right. I began experiencing numbness in my back, and after months of tests and uncertainty, doctors discovered a cluster of tumours in my spine. That’s when I was diagnosed with VHL.

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin